- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 6, 2025 | 28.98M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $537.55M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $531M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $0 |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $7.5M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $520.75M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $615.21M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.14B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.22B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $808.48M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $900.88M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.42B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.5B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $161.79M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $120.81M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 28.8M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $17.97M |
| Capex | Q1 2025 · Mar 31, 2024 | $4.77M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$29.35M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.68 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.68 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $61.72M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $36.1M |
| Net Income | Q1 2025 · Mar 31, 2024 | $19.47M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $31.8M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $157.89M |
| Revenue | Q1 2025 · Mar 31, 2024 | $295.14M |